A powerpoint presentation is now available that accompanied a meeting and talk on Monday 19 May from Dr Jill Sanders, the Director of the Canadian Agency for Drugs and Technologies in Health (CADTH), discussing CADTH, its history and development, its role in the Canadian healthcare system and lessons learnt.
Evolving HTA in North America: Informing Health System Decisions (PPT, 2MB, 3 mins 20secs)
About CADTH
CADTH is an independent not-for-profit agency funded by Canadian federal, provincial and territorial governments, the Canadian Agency for Drugs and Technologies in Health (CADTH) supports informed decisions about the uptake and use of drugs and other health technologies in Canada. As a national body, CADTH works with health care decision makers, industry, associations and other interested parties to ensure that all Canadians benefit from evidence-based information, recommendations and advice.
Initially established in 1989 as the Canadian Coordinating Office for Health Technology Assessment (CCOHTA), CADTH adopted its new name in April 2006 to better reflect its expanded mandate and the broader range of services and products it now offers to support informed decisions on health technologies throughout Canada. From an initial focus on assessing medical devices, CADTH's areas of focus now include assessing the cost and health effectiveness of drugs and health technologies and identifying and promoting best practices in drug prescribing and use.
CADTH is accountable to the federal, provincial and territorial Conference of Deputy Ministers of Health through the CADTH Board of Directors.
For further information on CADTH please go to http://www.cadth.ca/